BSI jobs board

Dendritic cells are versatile controllers of immunity with crucial roles in innate and adaptive immunity. In neonates these cells are qualitatively distinct from adults, presumably to establish early life immune balance essential for survival. The project aims to dissect the developmental and functional heterogeneity of dendritic cells at barrier organs in early life. The project that will be led by the candidate aims to define the cell intrinsic and extrinsic mechanisms that influence dendritic cell function using single cell technologies (such as single cell RNASeq, multiparameter flow cytometry), in vivo mouse models to deplete dendritic cells, as well as innovative imaging techniques.  The position is available in the group of Barbara Schraml at the Ludwig Maximilians University, Munich, Germany. The post is located in state of the art laboratories at the new Biomedical Center of the LMU with access to excellent dedicated core facilities for flow cytometry, bioimaging and bioinformatics.

You should be creative and a good team player wanting to take an active role in a young, dynamic and international research team. A doctoral degree in Immunology, Cell Biology or Biochemistry is expected, although applicants with a degree in physics or bioengineering and an interest in life sciences are also welcome to apply. Previous experience in immunology is desirable. Expertise in flow cytometry, gene expression profiling and/or working with in vivo models are a plus. Proficiency in English is required.

UMCG are seeking a highly talented and broadly oriented immunologist with strong expertise in translational research in transplantation immunology who is able to bridge the traditional borders of innate and adaptive immunity. The candidate should have an excellent track record of independent research with high quality publications and successful acquisition of funding.

The candidate should have a track record of successful collaboration with clinicians and a genuine interest in clinically relevant research aimed at improving patient care. The candidate has to be a strong team player to be able to develop a new research line within a large center with multiple partners and opportunities.

• The successful candidate is expected to build or extend an independent research line, at an internationally competitive level.

• Excellent scientific achievements in transplant immunology, as documented by internationally recognized research publications and presentations at scientific conferences.

• The candidate is expected to raise extramural research funding. A track record in securing external funding is an asset.

• Strong verbal and written communication skills.

• Affinity with teaching for (under)graduate students

This permanent, full time post as a Professor of Immunology is available from November 2019. 

The University of Exeter Medical School is renowned for its world-leading diabetes research, and has recently been awarded £million investment from Research England as part of ‘Expanding Excellence in England.’

Immunology is a priority for the Diabetes Centre of Excellence and the University of Exeter Medical School. We are keen to develop novel and exciting research into autoimmunity in Type 1 diabetes (T1D) in man by making multiple appointments at different levels.

To make progress in human Type 1 diabetes is likely to need novel approaches. Exeter encourages applications from innovative immunologists either working in Type 1 diabetes at present or from those with experience in other areas of human autoimmunity who may not have worked on Type 1 diabetes but have relevant approaches and techniques. The immunologists will be able to work on novel and pioneering approaches using unique human pancreas samples obtained at the time of diagnosis of type 1 diabetes. Equipment to support applicants includes preferential access to Next Generation Sequencing, state of the art cell sorters and a new high-resolution, automated, digital pathology system. Key collaborators for this post will be the Immunologists led by Professor Gordon Brown in the recently established Centre for Medical Mycology. The ultimate aim is to understand the underlying disease processes in order to understand mechanisms in T1D, to stimulate the development and application of novel immunotherapies and inform the design of new clinical trial

Applications are welcome from Professors with skills in these areas, both those who have already applied these skills to diabetes research and those who would be keen to do so.